Win Ratio as an Effect Size Measure Under Non‐Proportional Hazards: A Comparison With Difference in Restricted Mean Survival

审查(临床试验) 统计 估计员 数学 危险系数 可解释性 筛子(范畴论) 计量经济学 推论 标称水平 非参数统计 生存分析 比率估计器 比例危险模型 稳健性(进化) 度量(数据仓库) 频数推理 置信区间 样本量测定 截断平均数 危害 均方误差 统计推断
作者
Yuan Wu,Xiaofei Wang,Zhiguo Li
出处
期刊:Statistics in Medicine [Wiley]
卷期号:45 (10-12): e70554-e70554 被引量:2
标识
DOI:10.1002/sim.70554
摘要

When the proportional hazards assumption does not hold, the hazard ratio can misrepresent treatment effects in survival analysis. We evaluate the win ratio, originally proposed for prioritizing multiple outcomes, as an effect size measure for a single survival outcome under non-proportional hazards, and compare it with the difference in restricted mean survival time (RMST). We perform bootstrap-based inference for the win ratio under both right- and interval-censoring using plug-in estimators based on nonparametric maximum likelihood estimators or spline-based sieve maximum likelihood estimators of the survival functions. We also study stratified win ratio to mitigate confounding. Extensive simulations are conducted to assess and compare the performances of the win ratio and the difference in RMST under various types of alternatives encountered in practice. The simulation results show that the win ratio-based tests outperform RMST-based tests when treatment benefits arise early, whereas RMST is more sensitive to late-onset effects, and stratified win ratio maintains nominal type I error in the presence of confounding, unlike unstratified win ratio. As an illustration, we analyze right-censored and interval-censored progression-free survival in patients with multiple myeloma treated with two different regimens. The results of this article support reporting the win ratio, along with the difference in RMST, when the proportional hazards assumption is doubtful, offering complementary clinical interpretability and robustness across censoring mechanisms and treatment effect patterns.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
乐乐的应助被科研通管家采纳,获得10
刚刚
顾矜的应助被科研通管家采纳,获得10
刚刚
七禾完成签到,获得积分20
刚刚
chmyt完成签到,获得积分10
刚刚
CipherSage的应助被科研通管家采纳,获得10
刚刚
刚刚
酷波er的应助被科研通管家采纳,获得10
刚刚
DW的应助被科研通管家采纳,获得10
刚刚
桐桐的应助被科研通管家采纳,获得10
1秒前
SciGPT的应助被科研通管家采纳,获得10
1秒前
JamesPei的应助被科研通管家采纳,获得10
1秒前
1秒前
easynature发布了新的文献求助10
1秒前
1秒前
1秒前
Lucas的应助被科研通管家采纳,获得10
1秒前
1秒前
科目三的应助被科研通管家采纳,获得10
1秒前
在水一方的应助被科研通管家采纳,获得10
2秒前
英姑的应助被科研通管家采纳,获得10
2秒前
2秒前
所所的应助被科研通管家采纳,获得10
2秒前
笨笨发布了新的文献求助10
2秒前
2秒前
搜集达人的应助被Donson_Li采纳,获得20
2秒前
思源的应助被科研通管家采纳,获得10
2秒前
田様的应助被科研通管家采纳,获得10
2秒前
2秒前
Lyufang的应助被科研通管家采纳,获得10
2秒前
DW的应助被科研通管家采纳,获得10
3秒前
3秒前
Jee发布了新的文献求助10
3秒前
orixero的应助被科研通管家采纳,获得10
3秒前
酷酷柚子发布了新的文献求助10
3秒前
Xiao发布了新的文献求助10
3秒前
5秒前
biancaliu发布了新的文献求助10
5秒前
5秒前
Wxj246801完成签到,获得积分10
5秒前
6秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
Improving the wear resistance of vehicle gear oil by oil soluble LaF3 nanoparticles and typical additives of gear oil 500
Boundaries and Bodhisattvas 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8183204
求助须知:如何正确求助?哪些是违规求助? 9572482
关于积分的说明 21825940
捐赠科研通 7780074
什么是DOI,文献DOI怎么找? 3433945
关于科研通互助平台的介绍 2558060
邀请新用户注册赠送积分活动 2480166